Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell Death in the Origin and Treatment of Cancer
Andreas Strasser, David L. Vaux
Molecular Cell (2020) Vol. 78, Iss. 6, pp. 1045-1054
Open Access | Times Cited: 298

Showing 1-25 of 298 citing articles:

Emerging connectivity of programmed cell death pathways and its physiological implications
Sammy Bedoui, Marco J. Herold, Andreas Strasser
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 11, pp. 678-695
Closed Access | Times Cited: 723
Modes of Regulated Cell Death in Cancer
Elle Koren, Yaron Fuchs
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 245-265
Open Access | Times Cited: 294
A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
Zilong Bian, Rong Fan, Lingmin Xie
Genes (2022) Vol. 13, Iss. 5, pp. 851-851
Open Access | Times Cited: 264
Cell death pathways: intricate connections and disease implications
Matthias Kist, Domagoj Vucic
The EMBO Journal (2021) Vol. 40, Iss. 5
Open Access | Times Cited: 239
Programmed Cell Death Tunes Tumor Immunity
Jing Liu, Minjing Hong, Yijia Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 217
Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
Jia-hao Bao, Weicheng Lu, Hao Duan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 71
Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
Nan Xing, Qinyun Du, Sa Guo, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 47
Targeting endothelial permeability in the EPR effect
Behnaz Lahooti, Racheal G. Akwii, Fatema Tuz Zahra, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 212-235
Closed Access | Times Cited: 43
Crosstalk between metabolism and cell death in tumorigenesis
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential
Na Wu, Wenhui Zheng, Yundong Zhou, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102428-102428
Closed Access | Times Cited: 23
Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases
Kate E. Lawlor, James M. Murphy, James E. Vince
Immunity (2024) Vol. 57, Iss. 3, pp. 429-445
Closed Access | Times Cited: 22
Programming a Ferroptosis‐to‐Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy
Yaron Vinik, Avi Maimon, Vinay Dubey, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 18
Apoptosis in Cancer Biology and Therapy
Allison Moyer, Kosuke Tanaka, Emily H. Cheng
Annual Review of Pathology Mechanisms of Disease (2025) Vol. 20, Iss. 1, pp. 303-328
Closed Access | Times Cited: 4
Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Ferroptosis in Cancer: Mechanisms, Therapeutic Strategies, and Clinical Implications
Mina Pourhabib Mamaghani, Seyedeh Nasibeh Mousavikia, Hosein Azimian
Pathology - Research and Practice (2025) Vol. 269, pp. 155907-155907
Closed Access | Times Cited: 2
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
Rachel Thijssen, Sarah T. Diepstraten, Donia M. Moujalled, et al.
Blood (2021) Vol. 137, Iss. 20, pp. 2721-2735
Open Access | Times Cited: 101
Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness
Deborah Fanfone, Zhichong Wu, Jade Mammi, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 70
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Jack W. Scannell, Jim Bosley, John A. Hickman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 915-931
Open Access | Times Cited: 68
Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer
Han Li, You Yu, Yi Liu, et al.
Pharmacological Research (2022) Vol. 182, pp. 106306-106306
Closed Access | Times Cited: 67
Flavonoids: A Myth or a Reality for Cancer Therapy?
Cinzia Forni, Massimiliano Rossi, Ilaria Borromeo, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3583-3583
Open Access | Times Cited: 61
Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle
Liwen Ren, Li Wan, Xiangjin Zheng, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 1, pp. 194-208
Open Access | Times Cited: 58
Bcl-2 Family Members and the Mitochondrial Import Machineries: The Roads to Death
Lisenn Lalier, François M. Vallette, Stéphen Manon
Biomolecules (2022) Vol. 12, Iss. 2, pp. 162-162
Open Access | Times Cited: 50
Metabolic determinants of tumour initiation
Julia Brunner, Lydia W.S. Finley
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 3, pp. 134-150
Open Access | Times Cited: 47
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways
He Pang, Tingrui Wu, Zhonghua Peng, et al.
Journal of bone oncology (2022) Vol. 33, pp. 100415-100415
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top